An Ozempic and Wegovy factory in North Carolina that helps serve millions of Americans has failed an inspection, reports suggest.
The factory was found to have ‘objectionable’ conditions by the Food and Drug Administration (FDA).
Based in Clayton, North Carolina, the drug manufacturer now has three weeks to devise an action plan to rectify the issues or risk facing further action. Novo Nordisk, which owns the factory, says manufacturing is ‘ongoing’.
Read more of the original article from DailyMail
